NYSE · Healthcare · Medical Distribution · USA
Cardinal Health Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Distribution industry.
Cardinal Health supplies pharmaceuticals, medical devices, and related services to the healthcare industry. The company distributes branded and generic drugs and specialty pharmaceuticals to hospitals, pharmacies, and retailers. Its operations include manufacturing Cardinal Health branded medical and surgical products, operating nuclear pharmacies, distributing home medical supplies, and providing logistics services.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Cardinal Health Inc stock.
Overvalued: intrinsic value $186.71 per share, market price $252.65, margin of safety -35.3% (as of 2026-10-19).
Discounting its cash flows at 8.0% (average of 3 methods) values the shares at $186.71; the price of $252.65 is 35% above that value, and 80% of that value comes from beyond year five.
Leak Score: 54/100 on 10 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 11 Medical Distribution stocks
CAH is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 8.0% (average of 3 methods) values the shares at $186.71; the price of $252.65 is 35% above that value, and 80% of that value comes from beyond year five.
$186.71 per share (as of the 2026-10-19 close), against a market price of $252.65. That is a margin of safety of -35.3%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
The price asks for more growth than the company has delivered. It needs the future to beat the past. Yearly sales growth the price needs: 23.4%. Yearly sales growth it has sustained: 11.6%.
54 out of 100, which we rate "Weak Signal", on 10 of 12 value investing signals.